Maxeon Solar Technologies Announces First Half of 2025 Financial Results
-- First half of 2025 revenue of
-- Amid continued headwinds, the Company is committed to business transformation and fiscal discipline--
"Maxeon's financial results for the first half of 2025 continued to reflect challenges resulting from
Guo continued, "Recently enacted H.R. 1 (OBBBA) legislation in the
Hu continued, "As previously communicated, the Company will defer providing financial guidance and holding a conference call for the foreseeable future considering ongoing restructuring and macroeconomic uncertainties."
|
Selected Unaudited Financial Summary |
|||
|
|
|||
|
|
Six Months Ended |
||
|
(In thousands, except shipments) |
|
|
|
|
Shipments, in MW |
153.2 |
|
1,014 |
|
Revenue |
$ 39,041 |
|
$ 371,675 |
|
Gross loss(1) |
(14,809) |
|
(22,656) |
|
GAAP Operating expenses |
54,004 |
|
110,338 |
|
Net loss attributable to the stockholders(1) |
(65,458) |
|
(68,484) |
|
Capital expenditures |
1,268 |
|
36,923 |
|
|
|
||
|
|
Other Financial Data(1) |
||
|
|
Six Months Ended |
||
|
(In thousands) |
|
|
|
|
Non-GAAP Gross loss |
$ (15,005) |
|
$ (18,682) |
|
Non-GAAP Operating expenses |
42,500 |
|
78,700 |
|
Adjusted EBITDA |
(48,562) |
|
(87,013) |
|
|
|
|
(1) |
The Company's use of non-GAAP financial information, including a reconciliation to |
For more information
Maxeon's first half of 2025 financial results and management commentary can be found on Form 6-K by accessing the Financials & Filings page of the Investor Relations section of Maxeon's website at: https://corp.maxeon.com/investor-relations. The Form 6-
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements regarding: (a) our ability to (i) meet short-term and long-term material cash requirements, (ii) service our outstanding debts and make payments as they come due and (iii) continue as a going concern; (b) the success of our ongoing restructuring initiatives, including our attempts to refinance or equitize our debts, and our ability to execute on our plans and strategy; (c) our expectations regarding product pricing trends, demand and growth projections, including our efforts to enforce our intellectual property rights against our competitors; (d) disruptions to our operations and supply chain resulting from, among other things, government regulatory or enforcement actions, such as the denial of entry into the
The forward-looking statements can be also identified by terminology such as "may," "might," "could," "will," "aims," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and Maxeon's operations and business outlook contain forward-looking statements.
These forward-looking statements are based on our current assumptions, expectations and beliefs and involve substantial risks and uncertainties that may cause results, performance or achievement to materially differ from those expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to a number of risks. The reader should not place undue reliance on these forward-looking statements, as there can be no assurances that the plans, initiatives or expectations upon which they are based will occur. Factors that could cause or contribute to such differences include, but are not limited to: (1) challenges in executing transactions key to our strategic plans, transformation initiatives and other restructuring plans, as well as challenges in addressing regulatory and other obstacles that may arise; (2) our liquidity, substantial indebtedness, terms and conditions upon which our indebtedness is incurred, and ability to obtain additional financing for our projects, customers and operations and to refinance and/or equitize our debts; (3) an adverse final determination of the CBP investigation related to CBP's examination of Maxeon's compliance with the Uyghur Forced Labor Prevention Act; (4) our ability to manage supply chain shortages and/or excess inventory and cost increases and operating expenses; (5) potential disruptions to our operations and supply chain that may result from difficulties in hiring or retaining key personnel, epidemics, natural disasters, trade and military conflicts, including impacts of the war in
Use of Non-GAAP Financial Measures
We present certain non-GAAP measures such as non-GAAP gross loss, non-GAAP operating expenses and earnings before interest, taxes, depreciation and amortization ("EBITDA") adjusted for stock-based compensation, restructuring charges and fees, remeasurement loss on prepaid forward and physical delivery forward, gain on extinguishment of debt, net gain on divestment of subsidiaries and equity in income of unconsolidated investees and associated gains ("Adjusted EBITDA") to supplement our consolidated financial results presented in accordance with GAAP. Non-GAAP gross loss is defined as gross loss excluding stock-based compensation and restructuring (credit) charges and fees. Non-GAAP operating expenses is defined as operating expenses excluding stock-based compensation and restructuring charges and fees.
We believe that non-GAAP gross loss, non-GAAP operating expenses and Adjusted EBITDA provide greater transparency into management's view and assessment of the Company's ongoing operating performance by removing items management believes are not representative of our continuing operations and may distort our longer-term operating trends. We believe these measures are useful to help enhance the comparability of our results of operations across different reporting periods on a consistent basis and with our competitors, distinct from items that are infrequent or not associated with the Company's core operations as presented above. We also use these non-GAAP measures internally to assess our business, financial performance and current and historical results, as well as for strategic decision-making and forecasting future results. Given our use of non-GAAP measures, we believe that these measures may be important to investors in understanding our operating results as seen through the eyes of management. These non-GAAP measures are neither prepared in accordance with GAAP nor are they intended to be a replacement for GAAP financial data, should be reviewed together with GAAP measures and may be different from non-GAAP measures used by other companies.
As presented in the "Reconciliation of Non-GAAP Financial Measures" section, each of the non-GAAP financial measures excludes one or more of the following items in arriving to the non-GAAP measures:
- Stock-based compensation expense. Stock-based compensation relates primarily to equity incentive awards. Stock-based compensation is a non-cash expense that is dependent on market forces that are difficult to predict and is excluded from non-GAAP gross (loss) profit, non-GAAP operating expense and Adjusted EBITDA. Management believes that this adjustment for stock-based compensation expense provides investors with a basis to measure our core performance, including the ability to compare our performance with the performance of other companies, without the period-to-period variability created by stock-based compensation.
-
Provision for expected credit losses. This relates to the expected credit loss in relation to the financial assets under the Separation and Distribution Agreement dated
November 8, 2019 (the "SDA") entered into with SunPower Corporation ("SunPower") in connection with the Company's spin-off from SunPower. Such loss is excluded from non-GAAP operating expense and Adjusted EBITDA as this relates to SunPower's business which Maxeon did not and will not have economic benefits to, as the Company's involvement is solely through SunPower's indemnification obligations set forth in the SDA. As such, management believes that this is not part of core operating activity and it is appropriate to exclude the provision for expected credit losses from our non-GAAP financial measures as it is not reflective of ongoing operating results nor do these charges contribute to a meaningful evaluation of our past operating performance. - Restructuring charges and fees (credit). We incur restructuring charges, inventory impairment and other inventory related costs associated with the re-engineering of our IBC capacity, and fees related to reorganization plans aimed towards realigning resources consistent with our global strategy and improving its overall operating efficiency and cost structure. Restructuring charges and fees (credit) are excluded from non-GAAP operating expenses and Adjusted EBITDA because they are not considered core operating activities. Although we have engaged in restructuring activities and initiatives, past activities have been discrete events based on unique sets of business objectives. As such, management believes that it is appropriate to exclude restructuring charges and fees (credit) from our non-GAAP financial measures as they are not reflective of ongoing operating results, nor do these charges contribute to a meaningful evaluation of our past operating performance.
-
Gain on extinguishment of debt. This relates to the gain that arose from the substantial modification of our Green Convertible Senior Notes due 2025 and 2027 Notes in
June 2024 . Gain on debt extinguishment is excluded from Adjusted EBITDA because it is not considered part of core operating activities. Such activities are discrete events based on unique sets of business objectives. As such, management believes that it is appropriate to exclude the gain on extinguishment of debt from our non-GAAP financial measures as it is not reflective of ongoing operating results, nor do these charges contribute to a meaningful evaluation of our past operating performance. -
Net gain on divestment of subsidiaries. This relates to the gain on divestment in our "rest-of-the-world" distributed generation business and our business in
the Philippines , net of the associated cost directly attributable to such transactions. This is excluded from our Adjusted EBITDA financial measure because it is not reflective of core operating results. -
Remeasurement loss on prepaid forward and physical delivery forward. This relates to the mark-to-market fair value remeasurement of privately negotiated prepaid forward and physical delivery transactions. The transactions were entered into in connection with the issuance on
July 17, 2020 of the 6.50% Green Convertible Senior Notes due 2025 for an aggregate principal amount of$200 million . The prepaid forward is remeasured to fair value at the end of each reporting period, with changes in fair value booked in earnings. The fair value of the prepaid forward is primarily affected by the Company's share price. The physical delivery forward was remeasured to fair value at the end of the Note Valuation Period onSeptember 29, 2020 , and was reclassified to equity after remeasurement, and will not be subsequently remeasured. The fair value of the physical delivery forward was primarily affected by the Company's share price. The remeasurement loss on prepaid forward and physical delivery forward is excluded from Adjusted EBITDA because it is not considered core operating activities. As such, management believes that it is appropriate to exclude the mark-to-market adjustments from our Adjusted EBITDA as it is not reflective of ongoing operating results, nor do the loss contribute to a meaningful evaluation of our past operating performance. - Equity in income of unconsolidated investees and related gains. This relates to the gain on divestment for our investment in our former unconsolidated equity investment Huansheng JV. This is excluded from our Adjusted EBITDA financial measure as it is not reflective of our core operational performance. As such, management believes that it is appropriate to exclude such charges as they do not contribute to a meaningful evaluation of our performance.
|
Reconciliation of Non-GAAP Financial Measures |
|||
|
|
Six Months Ended |
||
|
(In thousands) |
|
|
|
|
Gross loss |
$ (14,809) |
|
$ (22,656) |
|
Stock-based compensation |
302 |
|
862 |
|
Restructuring (credit) charges and fees |
(498) |
|
3,112 |
|
Non-GAAP Gross loss |
$ (15,005) |
|
$ (18,682) |
|
|
|
|
|
|
GAAP Operating expenses |
$ 54,004 |
|
$ 110,338 |
|
Stock-based compensation |
(6,624) |
|
(11,252) |
|
Provision for expected credit losses |
(115) |
|
(11,462) |
|
Restructuring charges and fees |
(4,765) |
|
(8,924) |
|
Non-GAAP Operating expenses |
$ 42,500 |
|
$ 78,700 |
|
|
|
|
|
|
Net loss attributable to the stockholders |
$ (65,458) |
|
$ (68,484) |
|
Interest expense, net |
17,545 |
|
18,850 |
|
Provision for income taxes |
4,343 |
|
4,415 |
|
Depreciation |
2,383 |
|
20,668 |
|
Amortization |
82 |
|
448 |
|
EBITDA |
(41,105) |
|
(24,103) |
|
Stock-based compensation |
6,926 |
|
12,114 |
|
Provision for expected credit losses |
115 |
|
11,462 |
|
Gain on extinguishment of debt |
— |
|
(77,266) |
|
Net gain on divestment of subsidiaries |
(18,872) |
|
— |
|
Restructuring charges and fees |
4,267 |
|
12,036 |
|
Remeasurement loss on prepaid forward |
107 |
|
14,289 |
|
Equity in income of unconsolidated investees and related gains |
— |
|
(24,083) |
|
Adjusted EBITDA |
$ (48,562) |
|
$ (75,551) |
©2025
|
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (In thousands, except for shares data) |
|||
|
|
|||
|
|
As of |
||
|
|
|
|
|
|
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
$ 17,225 |
|
$ 28,895 |
|
Accounts receivable, net |
8,772 |
|
4,269 |
|
Inventories |
34,103 |
|
40,220 |
|
Prepaid expenses and other current assets |
25,513 |
|
20,363 |
|
Assets held for sale |
59,445 |
|
172,269 |
|
Total current assets |
$ 145,058 |
|
$ 266,016 |
|
Property, plant and equipment, net |
7,530 |
|
72,858 |
|
Operating lease right of use assets |
25,513 |
|
27,951 |
|
Other intangible assets, net |
441 |
|
523 |
|
Other long-term assets |
7,768 |
|
8,924 |
|
Total assets |
$ 186,310 |
|
$ 376,272 |
|
Liabilities and Equity |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
$ 47,480 |
|
$ 62,544 |
|
Accrued liabilities |
42,573 |
|
86,724 |
|
Contract liabilities, current portion |
74,500 |
|
74,312 |
|
Short-term debt |
482 |
|
462 |
|
Operating lease liabilities, current portion |
7,299 |
|
9,098 |
|
Liabilities classified as held for sale |
— |
|
105,368 |
|
Total current liabilities |
$ 172,334 |
|
$ 338,508 |
|
Long-term debt |
481 |
|
732 |
|
Contract liabilities, net of current portion |
2,500 |
|
3,333 |
|
Operating lease liabilities, net of current portion |
23,980 |
|
27,434 |
|
Convertible debt |
287,239 |
|
273,766 |
|
Deferred tax liabilities |
5,313 |
|
5,313 |
|
Other long-term liabilities |
16,109 |
|
15,551 |
|
Total liabilities |
$ 507,956 |
|
$ 664,637 |
|
Commitments and contingencies |
|
|
|
|
Net deficit: |
|
|
|
|
Common stock, no par value 16,932,760 and 16,711,109 issued and outstanding as |
$ — |
|
$ — |
|
Additional paid-in capital |
1,144,689 |
|
1,137,042 |
|
Accumulated deficit |
(1,471,498) |
|
(1,410,392) |
|
Accumulated other comprehensive loss |
(647) |
|
(20,492) |
|
Net deficit attributable to the Company |
(327,456) |
|
(293,842) |
|
Noncontrolling interests |
5,810 |
|
5,477 |
|
Net deficit |
(321,646) |
|
(288,365) |
|
Total liabilities and net deficit |
$ 186,310 |
|
$ 376,272 |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (In thousands, except per share data) |
|||
|
|
|||
|
|
Six Months Ended |
||
|
|
|
|
|
|
Revenue |
$ 39,041 |
|
$ 371,675 |
|
Cost of revenue |
53,850 |
|
394,331 |
|
Gross loss |
(14,809) |
|
(22,656) |
|
Operating expenses: |
|
|
|
|
Research and development |
14,618 |
|
19,322 |
|
Sales, general and administrative |
34,192 |
|
88,034 |
|
Restructuring charges |
5,194 |
|
2,982 |
|
Total operating expenses |
54,004 |
|
110,338 |
|
Operating loss |
(68,813) |
|
(132,994) |
|
Other income, net |
|
|
|
|
Interest expense |
(18,024) |
|
(20,177) |
|
Interest income |
479 |
|
1,327 |
|
Gain on extinguishment of debt |
— |
|
77,266 |
|
Other, net |
25,423 |
|
9,874 |
|
Other income, net |
7,878 |
|
68,290 |
|
Loss before income taxes |
(60,935) |
|
(64,704) |
|
Provision for income taxes |
(4,343) |
|
(4,415) |
|
Equity in income (losses) of unconsolidated investees |
— |
|
— |
|
Net loss |
(65,278) |
|
(69,119) |
|
Net (income) loss attributable to noncontrolling interests |
(180) |
|
635 |
|
Net loss attributable to the stockholders |
$ (65,458) |
|
$ (68,484) |
|
|
|
|
|
|
Net loss per share attributable to stockholders: |
|
|
|
|
Basic and diluted |
$ (3.89) |
|
$ (134.55) |
|
|
|
|
|
|
Weighted average shares used to compute net loss per share: |
|
|
|
|
Basic and diluted |
16,811 |
|
509 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (In thousands) |
|||
|
|
|||
|
|
Six Months Ended |
||
|
|
|
|
|
|
Cash flows from operating activities |
|
|
|
|
Net loss |
$ (65,278) |
|
$ (69,119) |
|
Adjustments to reconcile net loss to operating cash flows |
|
|
|
|
Depreciation and amortization |
2,465 |
|
21,116 |
|
Stock-based compensation |
6,926 |
|
12,114 |
|
Non-cash interest expense |
9,078 |
|
4,056 |
|
Gain on disposal of equity in unconsolidated investees |
— |
|
(24,083) |
|
Net gain on divestment of interest in subsidiaries |
(18,872) |
|
— |
|
Remeasurement of lease liability |
(2,070) |
|
— |
|
Deferred income taxes |
— |
|
(7) |
|
Loss on impairment of property, plant and equipment |
— |
|
1,542 |
|
Loss on impairment of right of use of asset |
— |
|
4,525 |
|
Loss (gain) on disposal of property, plant and equipment |
748 |
|
(837) |
|
Gain on debt extinguishment |
— |
|
(77,266) |
|
Remeasurement loss (gain) on prepaid forward |
107 |
|
14,289 |
|
(Utilization of) provision for inventory reserves |
(7,171) |
|
15,767 |
|
Provision for expected credit losses |
213 |
|
11,655 |
|
Other, net |
(148) |
|
1,048 |
|
Changes in operating assets and liabilities |
|
|
|
|
Accounts receivable |
(9,129) |
|
22,202 |
|
Inventories |
23,816 |
|
60,427 |
|
Prepaid expenses and other assets |
1,441 |
|
11,632 |
|
Operating lease right-of-use assets |
2,469 |
|
3,006 |
|
Accounts payable and other accrued liabilities |
(36,707) |
|
(33,018) |
|
Contract liabilities |
(98) |
|
(122,861) |
|
Operating lease liabilities |
(3,060) |
|
(3,364) |
|
Net cash used in operating activities |
(95,270) |
|
(147,176) |
|
Cash flows from investing activities |
|
|
|
|
Purchases of property, plant and equipment |
(1,268) |
|
(36,923) |
|
Purchases of intangible assets |
— |
|
(10) |
|
Net proceeds from divestment of subsidiaries |
83,236 |
|
— |
|
Proceeds from disposal of equity in unconsolidated investees |
— |
|
24,000 |
|
Proceeds from disposal of asset held for sale |
— |
|
462 |
|
Proceeds from disposal of property, plant and equipment |
1,109 |
|
824 |
|
Net cash from (used in) investing activities |
83,077 |
|
(11,647) |
|
Cash flows from financing activities |
|
|
|
|
Proceeds from debt |
— |
|
51,249 |
|
Repayment of debt |
— |
|
(74,572) |
|
Repayment of finance lease obligations |
(259) |
|
(258) |
|
Payment for transaction costs for ongoing equity issuance |
— |
|
(2,424) |
|
Net proceeds from issuance and modification of convertible notes and warrants |
— |
|
74,364 |
|
Net cash (used in) provided by financing activities |
$ (259) |
|
$ 48,359 |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(88) |
|
(94) |
|
Net decrease in cash, cash equivalents and restricted cash |
$ (12,540) |
|
$ (110,558) |
|
Cash, cash equivalents and restricted cash, beginning of period |
31,008 |
|
195,511 |
|
Cash, cash equivalents and restricted cash, end of period |
$ 18,468 |
|
$ 84,953 |
|
Non-cash transactions |
|
|
|
|
Property, plant and equipment purchases funded by liabilities |
$ 755 |
|
$ 1,910 |
|
Interest paid in shares |
— |
|
4,140 |
|
Interest paid by issuance of convertible notes |
3,142 |
|
5,519 |
|
Right-of-use assets obtained in exchange for lease obligations |
— |
|
7,986 |
The following table reconciles our cash and cash equivalents, and restricted cash reported on our Condensed Consolidated Balance Sheets and the cash, cash equivalents and restricted cash reported on our Condensed Consolidated Statements of Cash Flows as of
|
(In thousands) |
|
|
|
|
Cash and cash equivalents |
$ 17,225 |
|
$ 81,381 |
|
Restricted cash, current portion, included in Prepaid expenses and other current assets |
1,142 |
|
3,474 |
|
Restricted cash, net of current portion, included in Other long-term assets |
101 |
|
98 |
|
Total cash, cash equivalents and restricted cash shown in Condensed |
$ 18,468 |
|
$ 84,953 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/maxeon-solar-technologies-announces-first-half-of-2025-financial-results-302530561.html
SOURCE
